Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125374241 | 12537424 | 1 | I | 20160613 | 20160707 | 20160707 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-050670 | BRISTOL MYERS SQUIBB | 70.00 | YR | M | Y | 0.00000 | 20160707 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125374241 | 12537424 | 1 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | 3 MG, QD | Y | 9218 | 3 | MG | QD | ||||||
| 125374241 | 12537424 | 2 | I | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | 15 MG, UNK | Y | 0 | 15 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125374241 | 12537424 | 1 | Atrial fibrillation |
| 125374241 | 12537424 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125374241 | 12537424 | HO |
| 125374241 | 12537424 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125374241 | 12537424 | Coagulation time prolonged | |
| 125374241 | 12537424 | Drug interaction | |
| 125374241 | 12537424 | Epistaxis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |